Figure 4From: Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteersAllocation of subjects to the appropriate sequence groups during the study. S: Sequence groups; A: subjects receiving drug A (Nurofen® forte), B: subjects receiving drug B (Migränin®, E: subjects receiving Eudorlin® extra.Back to article page